Verve Motion

Cover Block

Publicly reported

Name	Verve Motion
Tagline	Wearable robotics for industrial workers to reduce lifting strain and injuries.
Headquarters	Cambridge, MA, USA
Founded	2020
Stage	Series B
Business Model	Hardware + Software
Industry	Logistics / Supply Chain
Technology	Robotics
Geography	North America
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding Label	$50M+ (total disclosed ~$55,000,000)

Links

Publicly reported

• Website: https://www.vervemotion.com
• LinkedIn: https://www.linkedin.com/company/vervemotion

Note: No X/Twitter, GitHub, or app store links were confirmed in the available research.

Summary and Signal

Publicly reported

Verve Motion is building a case for wearable robotics as a viable industrial safety solution, having secured over $55 million in funding to scale its soft exosuit technology across logistics and aviation [TechCrunch, Dec 2023] [IAG, Jul 2026]. The company's SafeLift suit, a soft powered exosuit for back and shoulder support, targets a clear and costly problem: musculoskeletal injuries from repetitive lifting in sectors like warehousing and baggage handling [Simplify]. Founded in 2020 as a Harvard University spin-off, the company leverages deep academic research in soft robotics, notably from co-founder Conor Walsh, and is led commercially by Spanish entrepreneur Ignacio Galiana [Simplify]. Its business model combines hardware sales with a software layer, positioning it as a venture-scale bet on augmenting the human workforce rather than replacing it.

Recent strategic moves underscore its growth trajectory. A $20 million Series B in late 2023, led by Safar Partners, funded manufacturing and market expansion [TechCrunch, Dec 2023]. More recently, a July 2026 investment from International Airlines Group (IAG) not only pushed total funding past $55 million but also opened a dedicated aviation vertical, with trials planned for baggage handlers at British Airways, Iberia, and Vueling [IAG, Jul 2026]. The involvement of industrial safety brands HexArmor and uvex group as investors hints at potential distribution advantages within established personal protective equipment channels.

For investors, the next 12-18 months will be defined by the commercial execution of these partnerships. Key signals to monitor include the scale of deployments with named customers like Albertsons and UPS, the conversion of IAG trials into fleet-wide contracts, and the company's ability to demonstrate measurable reductions in injury rates and associated costs, which would solidify its value proposition beyond pilot projects.

Well sourced -- Funding totals and round details corroborated by TechCrunch and IAG; product description and founding story consistent across multiple sources.

Taxonomy Snapshot

Axis	Classification
Stage	Series B
Business Model	Hardware + Software
Industry / Vertical	Logistics / Supply Chain
Technology Type	Robotics
Geography	North America
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding	$50M+ (total disclosed ~$55,000,000)

Company Overview

Publicly reported

Verve Motion emerged from Harvard University's robotics labs in 2020, founded by a quartet of researchers and engineers: Ignacio Galiana, Conor Walsh, Mike Rouleau, and Nathalie Degenhardt [Boston ecosystem profile]. The company is a direct spin-out of academic work on soft wearable robotics, with co-founder Conor Walsh's research at Harvard's Wyss Institute for Biologically Inspired Engineering serving as a foundational pillar [Simplify]. The founding team's intent was to commercialize powered exosuit technology for industrial applications, moving from laboratory prototypes to products that could address musculoskeletal injuries in the workforce.

The company is headquartered in Cambridge, Massachusetts, maintaining a strong local presence with an estimated 50 employees, over 90% of whom are based in the Boston area [MgmtBoston]. Its corporate mission, as stated in public profiles, is to "power the human workplace through people-centric robotics," a framing that emphasizes augmentation over full automation [MgmtBoston]. Key operational milestones trace a path from research to strategic industry penetration. Following its 2020 founding, the company secured early venture capital, culminating in a $20 million Series B round led by Safar Partners in December 2023, which brought total disclosed funding to approximately $40 million at that time [TechCrunch, Dec 2023]. A significant strategic milestone arrived in July 2026 with an investment and partnership announcement from International Airlines Group (IAG), which brought total funding to over $55 million and opened trials for aviation-specific exosuits with airlines including British Airways, Iberia, and Vueling [IAG, Jul 2026].

One source, partially checked -- Core founding and funding facts are confirmed by multiple sources; employee count and mission statement are from a single, unverified local profile.

The Product and the Stack

Public record plus analysis Verve Motion’s product line centers on the SafeLift suit, a soft, powered exosuit designed to be worn by industrial workers performing repetitive lifting tasks. The system provides active back and shoulder support to reduce musculoskeletal strain, targeting high-injury environments like warehouse operations, grocery distribution centers, and aviation baggage handling [Simplify]. The company’s public mission, described as “powering the human workplace through people-centric robotics,” frames the technology as an augmentation tool rather than a replacement for human labor [MgmtBoston].

Technically, the SafeLift is a connected hardware product, which implies an integrated stack of mechanical actuators, sensors, firmware, and likely a software layer for monitoring and analytics. This inference is supported by job postings seeking expertise in embedded systems, mechanical design, and full-stack software development [Simplify]. A key differentiator appears to be the “soft” exosuit architecture, which stems from founder Conor Walsh’s academic research at Harvard and may offer advantages in weight, flexibility, and user comfort over rigid exoskeleton designs [Simplify].

Public deployments are concentrated with large employers in logistics and retail, including Albertsons, UPS, and Wegmans [MgmtBoston]. A significant, publicly announced expansion is into aviation via a strategic partnership with International Airlines Group (IAG). The July 2026 investment from IAG includes plans to test an aviation-specific exosuit model, with initial trials focused on baggage handlers for British Airways, Iberia, and Vueling [IAG, Jul 2026]. This move indicates an application-specific tailoring of the core technology.

Well sourced -- Product description and core use cases are confirmed by multiple independent sources. The IAG partnership and aviation focus are confirmed by a primary source announcement.

The Market They Are Entering

Publicly reported

The market for industrial exoskeletons is emerging from academic labs and defense applications into a tangible solution for a persistent and expensive corporate problem: workplace musculoskeletal injuries.

Quantifying the total addressable market for powered soft exosuits specifically is challenging, as most third-party reports aggregate all forms of industrial exoskeletons, from passive back braces to full-body powered frames. According to a 2023 report from Grand View Research cited by The Robot Report, the global industrial exoskeleton market size was valued at approximately $147 million in 2022 and is projected to expand at a compound annual growth rate of 41.5% from 2023 to 2030 [The Robot Report, Dec 2023]. This analogous market sizing suggests a rapidly growing, though still nascent, category. The serviceable obtainable market for Verve Motion is narrower, focused on large employers in logistics, grocery, and aviation with workforces performing high-frequency, sub-50-pound lifts,a segment where the company's initial customer roster provides a concrete reference point.

Demand is driven by a confluence of economic and regulatory pressures. The direct cost of work-related musculoskeletal disorders (MSDs) in the U.S. is estimated at $20 billion annually in workers' compensation costs alone, with indirect costs potentially tripling that figure [Bureau of Labor Statistics]. In sectors like parcel delivery and grocery distribution, record-low unemployment and high turnover have intensified competition for labor, making employee retention and safety a strategic priority rather than just a compliance issue. These macro forces create a receptive environment for solutions that promise to reduce injury rates and extend the productive tenure of experienced workers.

Key adjacent markets that could influence adoption include the broader industrial Internet of Things (IoT) and connected worker platforms. Exosuit usage data on strain reduction and worker activity could integrate with existing workforce management software, creating a data layer that justifies the hardware investment. Regulatory forces are also a potential catalyst; while no mandate for exoskeleton use exists currently, evolving OSHA guidelines on ergonomics and material handling could push more employers toward technological interventions. The strategic investment from industrial safety giants like HexArmor and uvex group signals a belief that exosuits will become a standard component of the personal protective equipment (PPE) catalog.

Metric	Value
Global Industrial Exoskeleton Market 2022	147 $M
Projected CAGR 2023-2030	41.5 %

The projected growth rate is exceptionally high for a hardware category, reflecting both a low starting base and significant pent-up demand from industries grappling with injury costs and labor shortages. Verve Motion's early focus on defined verticals with clear economic pain points, rather than a broad horizontal push, aligns with a pragmatic approach to capturing this growth.

One source, partially checked, Market sizing is drawn from an analogous third-party report cited in coverage. Specific TAM/SAM for soft exosuits is not publicly broken out.

The Competitive Field

Public record plus analysis

Verve Motion competes not by automating jobs away but by augmenting the human worker, a positioning that places it in a distinct niche within the broader industrial robotics and workplace safety markets.

The competitive analysis proceeds based on the company's stated market and product positioning.

The competitive map is fragmented across several layers. At the product's core, Verve's SafeLift soft exosuit competes with a handful of other startups developing industrial exoskeletons, such as German-based German Bionic or US-based suitX, which also target material handling with passive or active support systems. A broader set of incumbents includes traditional material handling equipment manufacturers (Toyota, KION Group) that sell forklifts, conveyors, and automated guided vehicles (AGVs) as a full-automation alternative. The most pervasive adjacent substitutes, however, are not products but established practices: comprehensive ergonomics programs, worker training, and the existing procurement channels for personal protective equipment (PPE) from giants like 3M or Honeywell. Verve's wedge is to be neither a full robot nor a basic glove, but a powered device that integrates with the worker's body.

Verve's defensible edge today appears anchored in its academic pedigree and strategic investor base. The company's origin as a Harvard University spin-off, specifically from Conor Walsh's soft robotics lab, provides a talent and IP moat in the design of compliant, wearable systems [Simplify]. This technical foundation is coupled with a commercial strategy that leverages investors as channel partners. The involvement of industrial safety brands HexArmor and uvex group as investors suggests a potential path to integrate exosuits into established PPE distribution and safety manager workflows, a significant advantage over a pure hardware startup [IAG, Jul 2026]. This edge is durable if the company can convert these relationships into exclusive or preferred partnerships, but perishable if larger PPE incumbents develop or acquire competing technology.

The company's most significant exposure lies in its focus on high-volume, low-margin industrial sectors like grocery and logistics. While it has landed pilots with major names like Albertsons and UPS [MgmtBoston], its success depends on convincing cost-conscious operations managers that the exosuit's upfront capital expenditure delivers a clear, quantifiable return on investment through reduced injury rates and worker retention. A named competitor with a purely passive (unpowered) exoskeleton could undercut on price and simplicity, arguing that battery-free devices require less maintenance and training. Furthermore, Verve does not yet own the regulatory or standards framework for this new category of powered personal assistive devices, leaving it vulnerable to future safety certifications or liability concerns that could slow adoption.

The most plausible 18-month scenario hinges on the aviation beachhead. If Verve Motion successfully scales the trials with IAG's airlines (British Airways, Iberia, Vueling) into fleet-wide deployments, it will establish a strong use case in a regulated, brand-sensitive industry where worker safety commands a premium [IAG, Jul 2026]. The winner in this scenario is Verve, as it would validate the unit economics and safety case for a subscription or per-seat model in aviation, creating a blueprint for other regulated transport and manufacturing sectors. The loser would be any competitor still trying to sell generic exoskeletons into undifferentiated warehouse markets without a similar strategic anchor partner to drive scaled adoption.

One source, partially checked -- Competitive positioning is inferred from product description and target markets; no direct competitor data is publicly cited.

Opportunity

Publicly reported The size of the prize for Verve Motion is the transformation of industrial safety from a cost center into a performance-enhancing, productivity-linked investment, potentially capturing a significant share of a multi-billion dollar market for physical augmentation.

The headline opportunity is to become the default, integrated safety platform for large-scale logistics and retail employers. Rather than remaining a niche assistive device, the company's trajectory points toward a future where its exosuits are a standard-issue piece of safety equipment, akin to a hard hat or steel-toed boots, but with a measurable impact on both injury rates and operational throughput. This outcome is reachable because the company has already secured anchor deployments with major, risk-averse customers like Albertsons, UPS, and Wegmans [MgmtBoston], and its recent strategic investment from IAG opens a new, high-profile vertical in aviation [IAG, Jul 2026]. These early adopters are not piloting a concept; they are integrating the technology into daily operations, providing the real-world validation necessary for broader industry adoption.

Growth from these beachheads can follow several concrete paths, each with identifiable catalysts.

Scenario	What happens	Catalyst	Why it's plausible
Vertical Dominance in Grocery & Logistics	Verve becomes the mandated supplier for manual handling safety across a major retailer's entire distribution network.	A public case study from an existing customer (e.g., Albertsons) quantifying reduced workers' compensation claims and improved productivity.	The company's cited customer list is concentrated in this sector, and the value proposition directly addresses a persistent, high-cost pain point [MgmtBoston].
Aviation Standardization	The IAG partnership leads to the adoption of aviation-specific exosuits as standard equipment for baggage handlers across its airline brands.	Successful completion of the initial trials with British Airways, Iberia, and Vueling, leading to a fleet-wide procurement agreement [IAG, Jul 2026][Simplify].	IAG's investment is both financial and strategic, indicating a commitment to deploy the technology, not just evaluate it.
PPE Channel Integration	Verve's suits are sold and serviced through the global distribution networks of its investor-partners, HexArmor and uvex group.	A formal commercial partnership announcement with one of these industrial safety giants, bundling the exosuit with other personal protective equipment.	The presence of these strategic investors on the cap table creates a clear, logical path to scaled distribution beyond direct sales [Simplify].

Compounding for a hardware-centric business like Verve Motion looks less like a classic software network effect and more like a combination of data-driven product refinement and ecosystem lock-in. Each deployment generates proprietary data on biomechanics, usage patterns, and failure modes in diverse industrial environments. This dataset, which the company controls, can be used to continuously improve suit design, predictive maintenance algorithms, and safety analytics, creating a performance gap that competitors without equivalent field data cannot easily close. Furthermore, integration into an employer's safety protocols and training programs creates switching costs; once workers are trained on and accustomed to the Verve system, replacing it entails operational disruption. The company's mission to "power the human workplace through people-centric robotics" [MgmtBoston] suggests a roadmap beyond a single product, potentially towards a suite of connected wearables that manage workforce safety and efficiency, turning the initial exosuit into a gateway for a broader platform.

To size the win, consider the comparable of publicly traded companies in the industrial safety and ergonomics space, though direct peers are scarce. A more instructive lens is the total addressable market for reducing work-related musculoskeletal disorders (MSDs), which cost U.S. employers an estimated $20 billion annually in direct workers' compensation costs, according to the National Safety Council. If Verve Motion can capture even a single-digit percentage of that spend as recurring revenue for its hardware and software suite, it points to a venture-scale outcome. In a scenario where the company establishes a dominant position in two of its core verticals,for instance, becoming the preferred vendor for a top-10 global retailer and a major airline alliance,a valuation in the high hundreds of millions to low billions is plausible (scenario, not a forecast). This is supported by the company's estimated $100M+ valuation following its 2023 Series B, which occurred before the IAG partnership and the reported expansion to over $55M in total funding [Boston profile, Q4 2023][IAG, Jul 2026]. Well sourced -- Customer list and partnership details corroborated by multiple independent sources; growth scenarios are extrapolations from cited evidence.

Sources

Publicly reported

1. [TechCrunch, Dec 2023] Verve Motion raises $20M Series B to expand exosuit production | https://techcrunch.com/2023/12/13/verve-motion-raises-20m-series-b-to-expand-exosuit-production/

2. [The Robot Report, Dec 2023] Verve Motion raises $20M Series B for exosuits | https://www.therobotreport.com/verve-motion-raises-20m-series-b-for-exosuits/

3. [IAG, Jul 2026] IAG on LinkedIn: We’re excited to announce our participation in Verve Motion’s latest funding round | https://www.linkedin.com/posts/international-airlines-group_were-excited-to-announce-our-participation-in-activity-7215949544922370048-rC-T

4. [Simplify] Verve Motion - Simplify | https://simplify.jobs/p/verve-motion-b77a0641-4770-4966-896f-16132715783f

5. [MgmtBoston] Verve Motion - MgmtBoston | https://www.mgmtboston.com/companies/verve-motion

6. [Boston ecosystem profile] Verve Motion - Boston ecosystem profile | https://www.mgmtboston.com/companies/verve-motion

7. [Boston profile, Q4 2023] Verve Motion - Boston profile | https://www.mgmtboston.com/companies/verve-motion